Laetitia Ledein

Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis

Yannick Allanore, Oliver Distler, Alexandre Jagerschmidt et al. · Arthritis & Rheumatology · 2017 · 109 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Double-blind, Randomized, 8-week Placebo-controlled followed by a 16-week open label extension study, with the LPA1 receptor antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis

Yannick Allanore, Oliver Distler, Alexandre Jagerschmidt et al. · Zurich Open Repository and Archive (University of Zurich) · 2018 · 36 citations

Medicine, Clinical Sciences, Pharmacology +14

Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse

Laetitia Ledein, Bertrand Léger, Clara Dees et al. · British Journal of Pharmacology · 2020 · 34 citations · Full text

Medicine, Pathology, Pharmacology +17

High Glucose Activates YAP Signaling to Promote Vascular Inflammation

Jérémy Ortillon, Jean-Christophe Le Bail, Elise F. Villard et al. · Frontiers in Physiology · 2021 · 29 citations · Full text

Life Sciences, Biochemistry, Cell Biology +16